Work

Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein–Protein Interactions

Year: 2021

Type: review

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.1c00940

Authors: Shiyan Zhang, Jianfeng Lou, Yafang Li, Feilong Zhou, Ziqin Yan, Xilin Lyu, Yujun Zhao

Institutions: Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research, University of Science and Technology of China, Zhengzhou University

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, K. C. Wong Education Foundation

Awards: G2864310138, G3204223207, G7526503601, G8336512185

OpenAlex ID: W3183937858

FWCI: 1.179

Cites: 112

Cited by: 47

Related to: 10